系统性硬化症相关肌病:自身抗体谱、组织学特征与独立死亡风险
该回顾性队列研究纳入约翰霍普金斯硬皮病中心注册库3919例患者,其中672例(17%)存在骨骼肌病。肌病与弥漫型亚型、非裔美国人及初诊时病程较短相关,抗PM-Scl、U3-RNP和抗Ku抗体与肌病存在相关,抗着丝点抗体对肌病具有保护作用。肌病与死亡风险增加相关(单因素HR 1.59,95%CI 1.40-1.81),多因素分析中独立死亡风险HR 1.60(95%CI 1.32-1.93)。
要点
- 672/3919例(17%)SSc患者存在骨骼肌病。
- 肌病组更多为弥漫型(60.4% vs 32.6%)及非裔美国人(30.4% vs 13.9%)。
- 肌病与独立死亡风险增加相关(多因素HR 1.60,95%CI 1.32-1.93)。
核心结论
- SSc相关骨骼肌病与独特的临床及自身抗体谱相关,并独立增加死亡风险。
研究设计与样本
- 回顾性队列研究,纳入约翰霍普金斯硬皮病中心研究注册库中伴或不伴骨骼肌病的患者,共3919例。
主要发现
- 672例(17%)患者存在骨骼肌病。
- 肌病组弥漫型亚型比例60.4% vs 无肌病组32.6%(P<0.0001)。
- 肌病组非裔美国人比例30.4% vs 无肌病组13.9%(P<0.0001)。
- 肌病组初诊时病程均值4.52±6.2年 vs 无肌病组6.5±8.0年(P<0.00001)。
- 单因素Cox回归中肌病与死亡风险增加相关(HR 1.59,95%CI 1.40-1.81,P<0.0001)。
关键数值与推荐
- 抗PM-Scl、U3-RNP和抗Ku抗体与肌病存在相关。
- 抗着丝点抗体对肌病具有保护作用。
- 多因素Cox回归控制混杂因素后,肌病仍与独立死亡风险相关(HR 1.60,95%CI 1.32-1.93,P<0.0001)。
临床怎么用
- 原文指出这些发现强调早期检测的重要性,并需进一步研究肌病如何预测患者结局,以改善靶向治疗和生存。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Skeletal myopathy is common in systemic sclerosis (SSc), but its associated clinical manifestations and long-term outcomes are poorly characterized. The purpose of this study is to characterize patients with skeletal myopathy and define its impact on survival. METHODS: This retrospective cohort study included patients in the Johns Hopkins Scleroderma Center Research Registry with and without skeletal myopathy. Clinical data including autoantibody profiles and muscle histopathology were compared between those with and without myopathy. Survival analyses including Cox proportional hazards and regression analyses were performed. RESULTS: In the cohort, 672 (17%) of 3,919 patients had a skeletal myopathy. When compared to those without a myopathy, those with myopathy were more commonly of the diffuse subtype (60.4% vs 32.6%, P < 0.0001), African American (30.4% vs 13.9%, P < 0.0001), and with shorter disease duration at first visit (mean 4.52 ± SD 6.2 years vs mean 6.5 ± SD 8.0 years, P < 0.00001). Anti-PM-Scl, U3-RNP, and anti-Ku were associated with the presence of myopathy, whereas anticentromere was protective against myopathy. Myopathy was associated with an increased risk of death in univariate Cox regression analyses (hazard ratio [HR] 1.59, 95% confidence interval [CI] 1.40-1.81, P < 0.0001). In multivariate Cox proportional regression analyses, myopathy had an independent risk of death even after controlling for other confounders (HR 1.60, CI 1.32-1.93, P < 0.0001). CONCLUSION: Skeletal myopathy in SSc is associated with distinct clinical and autoantibody profiles, as well as independently increased risk of death. These findings highlight the importance of early detection and further investigation into how myopathy predicts patient outcomes, with the goal of improving targeted therapies and survival in this high-risk population.
引用
- Paik JJ, Connolly CM, Wigley F, et al. Systemic Sclerosis-Associated Myopathy in a Large Single-Center Cohort: Autoantibody Profiles, Histologic Features, and Independent Risk of Death. Arthritis Care Res (Hoboken). 2026. PMID: 41111344. doi:10.1002/acr.25672
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。